Lin JH - Search Results

1

CYP induction-mediated drug interactions: in vitro assessment and clinical implications.

Lin JH. Lin JH. Pharm Res. 2006 Jun;23(6):1089-116. doi: 10.1007/s11095-006-0277-7. Epub 2006 May 26. Pharm Res. 2006. PMID: 16718615 Review.

2

A naphthyridine carboxamide provides evidence for discordant resistance between mechanistically identical inhibitors of HIV-1 integrase.

Hazuda DJ, Anthony NJ, Gomez RP, Jolly SM, Wai JS, Zhuang L, Fisher TE, Embrey M, Guare JP Jr, Egbertson MS, Vacca JP, Huff JR, Felock PJ, Witmer MV, Stillmock KA, Danovich R, Grobler J, Miller MD, Espeseth AS, Jin L, Chen IW, Lin JH, Kassahun K, Ellis JD, Wong BK, Xu W, Pearson PG, Schleif WA, Cortese R, Emini E, Summa V, Holloway MK, Young SD. Hazuda DJ, et al. Among authors: lin jh. Proc Natl Acad Sci U S A. 2004 Aug 3;101(31):11233-8. doi: 10.1073/pnas.0402357101. Epub 2004 Jul 26. Proc Natl Acad Sci U S A. 2004. PMID: 15277684 Free PMC article.

3

Evaluation of drug interactions with P-glycoprotein in drug discovery: in vitro assessment of the potential for drug-drug interactions with P-glycoprotein.

Hochman JH, Yamazaki M, Ohe T, Lin JH. Hochman JH, et al. Among authors: lin jh. Curr Drug Metab. 2002 Jun;3(3):257-73. doi: 10.2174/1389200023337559. Curr Drug Metab. 2002. PMID: 12083320 Review.

4

Mechanistic studies on metabolic interactions between gemfibrozil and statins.

Prueksaritanont T, Zhao JJ, Ma B, Roadcap BA, Tang C, Qiu Y, Liu L, Lin JH, Pearson PG, Baillie TA. Prueksaritanont T, et al. Among authors: lin jh. J Pharmacol Exp Ther. 2002 Jun;301(3):1042-51. doi: 10.1124/jpet.301.3.1042. J Pharmacol Exp Ther. 2002. PMID: 12023536

5

Pharmacokinetic and pharmacodynamic variability: a daunting challenge in drug therapy.

Lin JH. Lin JH. Curr Drug Metab. 2007 Feb;8(2):109-36. doi: 10.2174/138920007779816002. Curr Drug Metab. 2007. PMID: 17305491 Review.

6

Transporter-mediated drug interactions: clinical implications and in vitro assessment.

Lin JH. Lin JH. Expert Opin Drug Metab Toxicol. 2007 Feb;3(1):81-92. doi: 10.1517/17425255.3.1.81. Expert Opin Drug Metab Toxicol. 2007. PMID: 17269896 Review.

7

Complicating factors in safety testing of drug metabolites: kinetic differences between generated and preformed metabolites.

Prueksaritanont T, Lin JH, Baillie TA. Prueksaritanont T, et al. Among authors: lin jh. Toxicol Appl Pharmacol. 2006 Dec 1;217(2):143-52. doi: 10.1016/j.taap.2006.08.009. Epub 2006 Sep 1. Toxicol Appl Pharmacol. 2006. PMID: 17055014

8

In vitro and in vivo CYP3A64 induction and inhibition studies in rhesus monkeys: a preclinical approach for CYP3A-mediated drug interaction studies.

Prueksaritanont T, Kuo Y, Tang C, Li C, Qiu Y, Lu B, Strong-Basalyga K, Richards K, Carr B, Lin JH. Prueksaritanont T, et al. Among authors: lin jh. Drug Metab Dispos. 2006 Sep;34(9):1546-55. doi: 10.1124/dmd.106.009878. Epub 2006 Jun 16. Drug Metab Dispos. 2006. PMID: 16782766

9

Interconversion pharmacokinetics of simvastatin and its hydroxy acid in dogs: effects of gemfibrozil.

Prueksaritanont T, Qiu Y, Mu L, Michel K, Brunner J, Richards KM, Lin JH. Prueksaritanont T, et al. Among authors: lin jh. Pharm Res. 2005 Jul;22(7):1101-9. doi: 10.1007/s11095-005-6037-2. Epub 2005 Jul 22. Pharm Res. 2005. PMID: 16028010

10

Novel HIV-1 protease inhibitors active against multiple PI-resistant viral strains: coadministration with indinavir.

Kevin NJ, Duffy JL, Kirk BA, Chapman KT, Schleif WA, Olsen DB, Stahlhut M, Rutkowski CA, Kuo LC, Jin L, Lin JH, Emini EA, Tata JR. Kevin NJ, et al. Among authors: lin jh. Bioorg Med Chem Lett. 2003 Nov 17;13(22):4027-30. doi: 10.1016/j.bmcl.2003.08.049. Bioorg Med Chem Lett. 2003. PMID: 14592500

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results